Bibliografía
 

2. Hudge GH: Agents affecting volume and composition of body fluids. In Gilman AG, Goodman LS, et al (eds): The pharmacological Basis of Therapeutics, de 7ª. New York. Mac Millan Publishing 1985.

3. Martinez Vea A. Metabolismo electrolítico y equilibrio ácido-base. Fisiopatología, clínica y tratamiento. S. Montoliu. Deshidratación y depleción de volumen. 1994. Doyma libros S.A. Cap. 3: 21-27.

4. Marino PL. The ICU Book. Traducción de Editorial Médica Panamericana S.A. efectuada por el Dr. A.Kaufman. Reimmpresión de la 1ª edición (1991) en 1994.

5. Robert Golub, MD; Joseph J. Sorrento JR, MD; Roberto Cantu JR, MD; David M. Nierman, MD; Ahamed Moideen, MD; David Stein, MD. Efficacy of albumin supplementation in the surgical intensive care unit. A prospective, randomized study.

6. The Handbook of Surgical Intensive Care. Practics of the Surgical residents al the Duke University Medical Center. III ed. 1993.

7. Amy  Imm, MD, and Richard W. Carlson. MD, Ph  D. Fluid resuscitation in circulatory shock. Critical Care Clinics 1993, Volume 9, number 2, 313 333.

8. Saunders WB. American College of Surgeon. Committee of trauma. Early Care of the injured patient. 3ª de Philadelphia. 1982: 24-26.

9. Edwards JD. A new debate: Colloid versus Crystalloid. Yearkbook of Intensive Care and Emergency Medicine. Springer-Verlag, Berlin. 1994; pp 154.

10. Rady MY, Nightingale P, Little RA, Edwards JD ( 1992) . Shock  index: A re-evaluation  in circulatory failure. Resuscitation 23: 227-234.

11. Amoroso P, Greenwood RN. Posture and central venous pressure measurement in circulatory volume depletion. Lancet 1989; 1: 258-260.

12. Shippy CR, Appel PL, Shoemaker WC. Realibility of clinical monitoring to asses blood volume in the critically ill patients. Crit Care Med 1984; 12: 107-112.

13. Vincent JL . Fluids for resucitation. Br J Anesth 1991; 67: 185-193.

14. Sibbald WJ. Fluid therapy in sepsis.En: K Reinhart, K Eyrich, C.Sprung. (eds) Sepsis: Current prospectives in pathophysiology and therapy. Berlin. Springer-Verlag 1994; 266-273.

15. Singer M. Using the waveform shape. Intensive Care Medicine 1994; 1 (1) 22-34.

16. Hauser CJ, Shoemaker WC, Turpin Y, et al: Oxygen transport resposes to colloids and crystalloides in critically ill surgical patients. Surg Gynecol Obstet 150: 811, 1980.

17. Holcroft JW, Trunkey DD: Extravascular lung water following hemorrhagic shock in the baboom . Ann Surg 180: 408, 1974.

18. Holcroft JW, Trunkey DD: Pulmonary extravasation of albumin during and after hemorrhagic shock in babooms. J. Surg Res 18: 91, 1975.

19. Karanko MS, Klossner JA, Laaksonen VO: Restoration of  volume by crystalloid versus colloid after coronary artery by-pass haemodynamics, lung water, oxygenation and outcome. Crit Care Med 15: 559, 1987.

20. Kleeman CR: Volume composition.In Massry SG, Glassock RJ (eds): Textbook of Nephrology, de 2ª. Baltimore, Williams and Wilkins, 1989, p 211.

21. Lowe RJ, Moss GS; Jilek J, et al: Crystalloid vs colloid in the etiology of pulmonary failure after trauma. A randomized trial in man. Surgery 81: 676, 1977.

22. Metildi LA, Shackford SR, Virgilio RW, et al: Crystalloid vs colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gynecol Obstet 158: 207, 1984.

23. Shoemaker WC, Hauser CJ: Critique of crystalloid vs colloid therapy in shock and shock lung. Crit Care Med 7: 117, 1979.

24. Griffith CA.The family of Ringer´s solutions. J.Natl intravenous Therap Assoc 1986; 9: 480-483.

25.  Bertil K. J. Wagner and Louis F. D`Amelio. Pharmacologic and clinical considerations in selecting crystalloid, colloidal. and oxygen arrying resuscitation fluid, part 1.Vol. l2. May. l993. Clinical Pharmacy 335 346.

26. Lowery BD, Cloutier CT, Carey LC: Electrolyte solutions in resuscitation in human hemorragic shock. Surg Gynecol Obstet 133: 273. 1971.

27. Trinkle JK, Rush BF, Eiseman B. Metabolism of  lactate following mayor blood loss, Surgery 63: 782, 1968.

28. Kramer GC, Perron PR, Lindsay C, et al. Small-volume resuscitation with hypertonic saline dextran solution. Surgery 1986; 100: 239-246.

29. Rowe GC, Mc Kenna DH, Corliss RJ, et al: Hemodynamic effects of hypertonic sodium chloride. J. Appl Physiol 32: 182; 1972.

30. Mellander S, Johansson B, Gray S, Jonsson O, Lundvall J, Ljung B. (1967). The effects of hyperosmolarity on intact and isolated vascular smooth muscle. Possible role in exercise hyperemia: Angiologica 4: 310-322.

31. Kien ND, Kramer GC, White DA (1990). Inmediate increase in cardiac contractility following hypertonic saline infusion. Eur Surg Res 22: 293-295.

32. Shoemaker WC, Ayres S, Grenvick a; Holbrook PR, Leigh Thompson W. Textbook of critical Care. 2ª edition 1989.W.B. Saunders Company. Philadelphia. Reanimación con líquidos y coloides. Cap 119; 1137-1153.

33. Maningas PA, Bellamy RF: Hypertonic sodium chloride solutions for the prehospital management of traumatic hemorrhagic shock: A possible improvement in the standard of care? Ann Emerg Med 1986; 1: 1411-1414.

34. Peskind ER, Radant A, Dobie DJ, et al ( 1993 ). Hypertonic saline infusion increases plasma norepinephrine concentrations in normal men. Psychoneuroendocrinology 18: 103-113.

35. Wade CE, Hannon JP, Bossone Ca et al ( 1991) Neuroendocrinine response to hypertonic saline/dextran resuscitation following hemorrage. Circ Shock 35: 37-43.

36. Mc Kee AC, Winkelman MD, Banker BQ. Central pontino myelinolysis in severely burned patients: relationship to hyperosmolality. Neurology 1988; 38: 1211-1287.

37. Kenneth M. Sutin, MD,; Keith J. Ruskin, MD and Brian S.Kaufman, MD. Intravenous fluid therapy in neurologic injury. Critical Care Clinics, vol 8, number 2. April 1992: 367-401.

38. Ronning G, Busund R, Reuhaug A ( 1993). Resuscitation of pigs with haemorrhagic shock an intraosseous hyperosmotic solution and transfusion of autologous whole blood.Eur J. Surg 159: 133-139.

39. Runyon DE, Brutting SP, Dubick MA, Clifford CB, Kramer GC ( 1994 ). Resuscitation from hypovolemia in swine with intraosseous infusion of a saturated salt-dextran solution. J Trauma 36: 11-19.

40. Gomez Bozares P, Torroba Teroba I: La fluidoterapia en Urgencias. Medicina Integral; Vol 27, número 4; Febrero 1996; 151-157.

41. Palacios Rubio V. Soluciones de sustitución del volumen plasmático. Ginestal cap. 60, p 983.

42. Lewis RT: Album: Role and discriminative use in surgery. Can J Surg 23: 322, 1990.

43. Thompson WL: Rational use of albumin and plasma substituts. John Hopkins Med J.136: 220, 1975.

44. Rosenoer VM,  Skillman JJ, Hastings PR, et al: Albumin synthesis and nitrogen balance in postoperative patients Surgery 87: 305, 1980.

45. Dahn MS, Lucas CE, Ledgerwood AM, et al: Negative inotropic effects of albumin resuscitation for shock Surgery 86: 235. 1979.

46. Lucas CE, Weaver D, Higgins RF, et al: Effect of album vs non-albumin resuscitation on plasma volumen and renal excretory function. J. Trauma 18: 564, 1978.

47.  Baron JF  (1991) Clinical use of  hydroxyethyl  starches, In: Vincent JL (de) Update in intesive care and emergncy medicine Vol.. 14 Springer verlag, Berlin, New York, London,  pp  4 03 414.

48. Mishler J: Synthetic plasma volume expanders, their pharmacology, safety and clinical efficacy. Clinical efficacy. Clin Haematol 13: 75, 1984.

49. Hankeln K, Radel C, Beez M, et al: Comparison of hydroxyethyl starch and lactated Ringer´s solution on hemodynamics and oxygen transport of  critically ill patients in prospective studies. Crit Care Med 17: 133, 1989.

50. Strauss RG, Stanfield C, Henriksen RA, et al : Pentastarch may cause fewer effects on coagulation than Metastarch. Transfusion 28: 257, 1988.

51. Stump DC, Strauss RG, Henriksen RA, et al: Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 25: 349, 1985.

52. Kohler H, Zschiedrich H, Cleren R, et al: The effects sf 500 ml 10% Hydroxyethyl starch 200/0,5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunters. Anesthesist 31: 61, 1982.

53. Heughan C, Ninikoski J, Hunt TK: Effect of excessive infusion of saline solution on tissue oxygen transport. Surg Gynecol Obstet 135: 257, 1972.

54. Lunsgaard-Hansen P, Tschirren B. Develop Biol Standard 1981; 48: 251-256.

55. Fortune JB, Feustel PJ, Saifi J, et al : Influence of hematocrit on cardiopulmonary function after acute hemorrhage. J Trauma 1987; 27: 243.

56. Mitsumo T, Ohyanagi H, Naito R. Clinical studies of a perffluorochemical whole blood susbtitute ( Fluosol-DA) Ann Surg 1982; 195: 60.

57. Moss GS, De Woskin R, Rosen AL, et al: Transport of oxygen and carbon dioxide by hemoglobin-saline solution in the red cell-free primate. Surg Ginecol Obstet 1976; 142: 357.

58. Savitsky JP, Doczi J, Black J, et al: A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978; 23: 73-80.

59. Deby-Dupont G, Pincemail J, Lamy M. Hemoglobin-based Red Cell Sustitutes: Preliminary Human Studies. In : JL Vincent (de) Yearbook of Intensive Care and Emergency Medicine. Springer-Verlag, Berlin. 1994; pp. 264-275.

60. Tsuchida E. Synthesis and characteriztion of artificial red-cell  (ARC).  Biomat Artif Cells Immob Biotech 1992; 20: 337-344.

61. Chang TMS, Varma R. Effect of a single replacement of one of ringer lactate, hypertonic saline/ dextran, 7 g. albumin, stromafree hemoglobin, o raffinose plyhemoglobin or wole blood on the log term survival of  unanesthetuzed rats with lethal hemorrhagic shock after 67 %  acute blood loss. Biomat Artif  Cells Immob Biotech 1992;  20: 503 5l0.

62. Malcom D, Kissinger D, Garrioch M. Diaspirin cross-linked hemoglobin solution as a resuscitative fluid following severe hemorrage in the rat. Biomat Artif Cells Immob Biotech 1992; 20: 495-497.

63. Vlahakes GJ, Lee R, Jacobs EE, et al.: Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 1990; 100: 379-388.

64. Wehry M, Penner J, Campbell F, et al.: Exchange-Transfusion with pyridoxalated polymerized hemoglobin: Effects on liver PO2. Circ Shock 1987; 23: 249-261.

65. Gould SA, Sehgal LR, Rosen AL, et al: Hemoglobin solution: Is a normal (Hb) or P50 more important?. J Surg Res 1982; 33: 189-193.

66. Powell CC, Shulz SC, Burris DG, et al: Subcutaneous oxygen tension: Auseful adjunct in assessment of perfusion status. Crit Care Med 1995; 23: 867-873. 8: 580.

67. Sharma AC, Gulati A: Yohimbine modulates diaspirin crosslinked hemoglobin induced systemic hemodynamics and regional circulatory effects. Crit Care Med 1995; 23: 874-884.

68. Safar P. Resuscitation from severe hemorrhage In : IRRC´94. Crit Care Med 1996; 24 (Suppl): S20.

69. Clark LC, Gollan F. Survival of mammals breathing organic liquids equilibrated  with oxygen al atmospheric pressure. Science l996; l52: l755 l756.

70. Faithfull NS. The Role of Perfluorochemicals in surgery and the ITU. In: JL Vincent (de) Yearkbook of Intensive Care and Emergency Medicine. Springr-Verlag, Berlin 1994; pp 237-251.

71. Gould SA, Rosen AL, Sehgal LR, et al. Fluosol-DA as a red-cell substitute in acute anemia. N Engl J Med 1986; 314: 1653-1656.

72. Tremper KK, Friedman AE, Levine EM, et al. The  preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N Engl J Med 1982; 307: 277-283.

73. Tremper KK, Friedman AE, Levine EM, et al. : The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid-Fluosol-DA. N Engl J Med 1982; 307: 277.

74. Marvick C. FDA Committee Questions Fluosol efficacy; US approval not imminent. JAMA 1983; 250: 2585-2586.

75. Gould SA, Rosen AL, Sehgal LR, et al: Fluosol-DA as a red-cell substitute in acute anemia. N Engl J Med 1986; 314: 1653.

76. Anderson   HV,  Leimgruber  PP, Roubin GS,  et al. distal coronary artery perfusion during percutaneous transluminal coronary angioplasty with oxygenated  Fluosol. Am j Cardiol 1990; 66: 279-284.

77. Kent KM, Cleaman MW, Cowly MJ, et al: Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol, Am J Cardiol 1990; 66: 279-284.

78.  Glogar DG, Kloner RA, Muller J, et al. Fluorocarbons reducemmyocardial ischemia damage after coronary occlusion. Science. 1981; 211: 1439-1441.

79. Rice HE, Virmani R, Hart CL, et al. Dose-dependent reduction of miocardial infarct size with the perfluorochemical Fluosol-DA. Am Heart J 1990; 120: 1039-1046.

80. Faithfull NS, Erdmann W, Fennema M, et al. Effects of haemodilution with fluorocarbons or dextran on oxygen tensions in the acutely ischaemic myocardium. Br J Anaesth 1986; 58: 1031-1040.

81. Forman MB, Pitarys CJ, Vildibill HD, et al. Pharmacologic peturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion. J Am Coll Cardiol  1992; 86 (suppl) 1: 642.

82. Wall TC, Topol EJ, Califf RM, et al. Tami: preliminary report or a prospective randomized trial of intravenous Fluosol in acute myocardial infarction. Circulation 1992; 86 (Suppl) 1: 642.

83. Chen HS, Yang ZH. Perfluorocarbon as blood substitute in clinical applications and in war casualties. Biomater Artif Cells Artif Organs 1988; 16: 403-409.

84. Chilaya SM, Svaladze GA, Chkhaiidze ZA, et al. Auxyllary fluorocarbon blood oxygenation. Anesteziol Reanimatol 1986; 3: 60-63.

85. Vercelloti GM, Hammerschmidt DE, Jacob HS, et al. Activation of plasma complement © by perfluorocarbon artificial blood ( Fluosol-DA): Mechanicsm and prevention of resulting adverse pulmonary reactions. Clin Res 1981; 29: 572A.

86. Goodin TH, Grossbard EG, Kaufman RJ, et al: A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock: A prospective, randomized, controlled study Crit Care Med 1994; 22: 680-689.

87. Wahr JA, Trouwborst A, Spence RK, et al.: A pilote study of effects of a perflubron, AF 0104 emulsion, in PvO2 in anesthesized surgery patients . Anesth Analg 1996; 82: 103-107.

88. Ogilby JD, Noma S, Diloretto G, et al. Preservation of myocardial function during ischemia with intracoronary perfluorooctylbromide ( Oxygent ). Biomat Art Cells Immob Biotech 1992; 20: 973.

89. Ortiz A.: Medio Interno 1ª de Ruan S.A. 1986.

90. Marilyn T. Hampt, MD, Brian S. Kaufman; MD, and Richard W. Carlson, MD, PhD. Fluid resuscitation in patients with increased vascular permeability. Critical Care Clinics. Vol 8, number 2. April 1992: 341-353.

91. Rackow EC, Fein IA, Siegel J,. The relationship os the colloid osmotic-pulmonary artery wedge pressure gradient to pulmonary edema and mortality in critically ill patients. Chest 1982; 82: 433-437.

92. Weil MH, Henning RJ, Moissette M, Michaels S. Relationship between colloid osmotic pressure and pulmonary artery wedge pressure in patients with acute cardiorespiratory failure. Am J Med 1978; 64: 643-649.